Journal of Substance Abuse Treatment
Volume 29, Issue 4 , Pages 259-265 , December 2005

Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment

  • Anja Dobler-Mikola, Ph.D.

      Affiliations

    • Association for Risk Reduction in Use of Drugs, Geschäftsstelle, Konradstrasse 1, CH-8005 Zurich, Switzerland
    • ,
  • Josef Hättenschwiler, M.D.

      Affiliations

    • Department of Psychiatry, Burghölzli Hospital, University of Zurich, Lenggstrasse 31, CH-8032 Zurich, Switzerland
    • ,
  • Daniel Meili, M.D.

      Affiliations

    • Association for Risk Reduction in Use of Drugs, Geschäftsstelle, Konradstrasse 1, CH-8005 Zurich, Switzerland
    • ,
  • Thilo Beck

      Affiliations

    • Association for Risk Reduction in Use of Drugs, Geschäftsstelle, Konradstrasse 1, CH-8005 Zurich, Switzerland
    • ,
  • Edi Böni

      Affiliations

    • Association for Risk Reduction in Use of Drugs, Geschäftsstelle, Konradstrasse 1, CH-8005 Zurich, Switzerland
    • ,
  • Jiri Modestin, M.D.

      Affiliations

    • Department of Psychiatry, Burghölzli Hospital, University of Zurich, Lenggstrasse 31, CH-8032 Zurich, Switzerland
    • Corresponding Author InformationCorresponding author. Tel.: +41 44 384 21 11; fax: +41 44 384 27 19.

Received 5 May 2005 ,Revised 1 June 2005 ,Accepted 1 August 2005.

References 

  1. Alterman AI, Rutherford MJ, Cacciola JS, McKay JR, Boardman CR. Prediction of 7 months methadone maintenance treatment response by four measures of antisociality. Drug and Alcohol Dependence. 1998;49:217–223
  2. American Psychiatric Association . Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed.. Washington: American Psychiatric Association; 1994;
  3. Anglin MD, Almog IJ, Fisher DG, Peters KR. Alcohol use by heroin addicts: Evidence for an inverse relationship. A study of methadone maintenance and drug-free treatment samples. American Journal of Drug and Alcohol Abuse. 1989;15:191–207
  4. Avants SK, Margolin A, McKee S. A path analysis of cognitive, affective, and behavioral predictors of treatment response in a methadone maintenance program. Journal of Substance Abuse. 1999;11:215–230
  5. Ball JC, Ross A. The effectiveness of methadone maintenance treatment. New York: Springer; 1991;
  6. Bertschy G. Methadone maintenance treatment: An update. European Archives of Psychiatry and Clinical Neuroscience. 1995;245:114–125
  7. Bianchi E, Maremmani I, Meloni D, Tagliamonte A. Controlled use of heroin in patients on methadone maintenance treatment. Journal of Substance Abuse Treatment. 1992;9:383–387
  8. Borg L, Broe DM, Ho A, Kreek MJ. Cocaine abuse sharply reduced in an effective methadone maintenance program. Journal of Addictive Diseases. 1999;18:63–75
  9. Cacciola JS, Rutherford MJ, Alterman AI, McKay JR, Snider EC. Personality disorders and treatment outcome in methadone maintenance patients. Journal of Nervous and Mental Disease. 1996;184:234–239
  10. Camacho LM, Bartholomew NG, Joe GW, Cloud MA, Simpson DD. Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance. Drug and Alcohol Dependence. 1996;41:1–7
  11. Caputo F, Addolorato G, Domenicali M, Mosti A, Viaggi M, Trevisanim F, et al. Short-term methadone administration reduces alcohol consumption in non-alcoholic heroin addicts. Alcohol and Alcoholism. 2002;37:164–168
  12. Chatham LR, Rowan-Szal GA, Joe GW, Simpson DD. Heavy drinking, alcohol-dependent vs. nondependent methadone-maintenance clients: A follow-up study. Addictive Behaviors. 1997;22:69–80
  13. el-Bassel N, Schilling RF, Turnbull JE, Su KH. Correlates of alcohol use among methadone patients. Alcoholism, Clinical and Experimental Research. 1993;17:681–686
  14. Epstein DH, Preston KL. Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against. Addiction. 2003;98:269–279
  15. Esteban J, Gimeno C, Barril J, Aragones A, Climent JM, de la Cruz Pellin M. Survival study of opioid addicts in relation to its adherence to methadone maintenance treatment. Drug and Alcohol Dependence. 2003;70:193–200
  16. Favrat B, Rao S, O'Connor PG, Schottenfeld R. A staging system to predict prognosis among methadone maintenance patients, based on admission characteristics. Substance Abuse. 2002;23:233–244
  17. Gollnisch G. Multiple predictors of illicit drug use in methadone maintenance clients. Addictive Behaviors. 1997;22:353–366
  18. Grella CE, Anglin MD, Wugalter SE. Cocaine and crack use and HIV risk behaviors among high-risk methadone maintenance clients. Drug and Alcohol Dependence. 1995;37:15–21
  19. Grella CE, Anglin MD, Wugalter SE. Patterns and predictors of cocaine and crack use by clients in standard and enhanced methadone maintenance treatment. American Journal of Drug and Alcohol Abuse. 1997;23:15–42
  20. Hartel DM, Schoenbaum EE, Selwyn PA, Kline J, Davenny K, Klein RS, et al. Heroin use during methadone maintenance treatment: The importance of methadone dose and cocaine use. American Journal of Public Health. 1995;85:83–88
  21. Hillebrand J, Marsden J, Finch E, Strang J. Excessive alcohol consumption and drinking expectations among clients in methadone maintenance. Journal of Substance Abuse Treatment. 2001;21:155–160
  22. Hser YI, Anglin MD, Powers K. Longitudinal patterns of alcohol use by narcotics addicts. Recent Developments in Alcoholism. 1990;8:145–171
  23. Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic. 2003;2
  24. Maxwell S, Shinderman M. Optimizing response to methadone maintenance treatment: Use of higher-dose methadone. Journal of Psychoactive Drugs. 1999;31:95–102
  25. McLellan AT, Luborsky L, O'Brien CP, Woody GE. An improved evaluation instrument for substance abuse patients. The Addiction Severity Index. Journal of Nervous and Mental Disease. 1980;168:26–33
  26. Morral AR, Belding MA, Iguchi MY. Identifying methadone maintenance clients at risk for poor treatment response: Pretreatment and early progress indicators. Drug and Alcohol Dependence. 1999;55:25–33
  27. Morral AR, Iguchi MY, Belding MA, Lamb RJ. Natural classes of treatment response. Journal of Consulting and Clinical Psychology. 1997;65:673–685
  28. Norusis MJ. SPSS professional statistics 6.1. Chicago, IL: SPSS; 1994;
  29. Research Association of Therapeutic Communities for Drug Users (1999). Annual report for 1998 including comparison data 1995-1998. Addiction Research Institut Zürich, Research Report no. 76, unpublished.
  30. Rutherford MJ, Cacciola JS, Alterman AI, McKay JR, Cook TG. Contrasts between admitters and deniers of drug use. Journal of Substance Abuse Treatment. 2000;18:343–348
  31. Schottenfeld RS, Pakes JR, Kosten TR. Prognostic factors in buprenorphine- versus methadone-maintained patients. Journal of Nervous and Mental Disease. 1998;186:35–45
  32. Schottenfeld RS, Pakes JR, Oliveto A, Ziedonis D, Kosten TR. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Archives of General Psychiatry. 1997;54:713–720
  33. Simpson DD, Joe GW, Rowan-Szal GA. Drug abuse treatment retention and process effects on follow-up outcomes. Drug and Alcohol Dependence. 1997;47:227–235
  34. Uchtenhagen A, Dobler-Mikola A, Steffen T, Gutzwiller F, Blättler R, Pfeifer S. Prescription of narcotics for heroin addicts. Main results of the Swiss National Cohort Study. Basel: Karger; 1999;
  35. Ward J, Mattick R, Hall W. Key issues in methadone maintenance treatment. National Drug and Alcohol Research Centre. Kensington, Australia: University of New South Wales Press; 1992;
  36. In:  Ward J,  Mattick RP,  Hall W editor. Methadone maintenance treatment and other opioid replacement therapies. Amsterdam: Harwood Academic Publishers; 1998;p. 17–57
  37. Wasserman DA, Weinstein MG, Havassy BE, Hall SM. Factors associated with lapses to heroin use during methadone maintenance. Drug and Alcohol Dependence. 1998;52:183–192
  38. World Health Organization . Tenth revision of the International Classification of Diseases, Chapter V (F): Mental and behavioural disorders. Clinical descriptions and diagnostic guidelines. Geneva: WHO; 1991;

PII: S0740-5472(05)00168-6

doi: 10.1016/j.jsat.2005.08.002

Journal of Substance Abuse Treatment
Volume 29, Issue 4 , Pages 259-265 , December 2005

Article Tools